Research ArticleArticle
A Novel Pathway for Arsenic Elimination: Human Multidrug Resistance Protein 4 (MRP4/ABCC4) Mediates Cellular Export of Dimethylarsinic Acid (DMAV) and the Diglutathione Conjugate of Monomethylarsonous acid (MMAIII).
Mayukh Banerjee, Michael W Carew, Barbara A Roggenbeck, Brayden D. Whitlock, Hua Naranmandura, X.Chris Le and Elaine M Leslie
Molecular Pharmacology May 28, 2014, mol.113.091314; DOI: https://doi.org/10.1124/mol.113.091314
Mayukh Banerjee
1 University of Alberta;
Michael W Carew
1 University of Alberta;
Barbara A Roggenbeck
1 University of Alberta;
Brayden D. Whitlock
1 University of Alberta;
Hua Naranmandura
2 Zhejiang University
X.Chris Le
1 University of Alberta;
Elaine M Leslie
1 University of Alberta;
Jump to comment:
No eLetters have been published for this article.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
Research ArticleArticle
A Novel Pathway for Arsenic Elimination: Human Multidrug Resistance Protein 4 (MRP4/ABCC4) Mediates Cellular Export of Dimethylarsinic Acid (DMAV) and the Diglutathione Conjugate of Monomethylarsonous acid (MMAIII).
Mayukh Banerjee, Michael W Carew, Barbara A Roggenbeck, Brayden D. Whitlock, Hua Naranmandura, X.Chris Le and Elaine M Leslie
Molecular Pharmacology May 28, 2014, mol.113.091314; DOI: https://doi.org/10.1124/mol.113.091314
Research ArticleArticle
A Novel Pathway for Arsenic Elimination: Human Multidrug Resistance Protein 4 (MRP4/ABCC4) Mediates Cellular Export of Dimethylarsinic Acid (DMAV) and the Diglutathione Conjugate of Monomethylarsonous acid (MMAIII).
Mayukh Banerjee, Michael W Carew, Barbara A Roggenbeck, Brayden D. Whitlock, Hua Naranmandura, X.Chris Le and Elaine M Leslie
Molecular Pharmacology May 28, 2014, mol.113.091314; DOI: https://doi.org/10.1124/mol.113.091314
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement